Suppression of the Chemically Transformed Phenotype of BHK Cells by a Human cDNA

References

• Bishop, J. M. 1991. Molecular themes in oncogenesis. Cell 64:235-248.
   PubMed Web of Science ®Google Scholar
• Bouck, N. P., and G. DiMayorca. 1976. Somatic mutation as the basis for malignant transformation of BHK cells by chemical carcinogens. Nature (London) 264:722-727.
   PubMed Web of Science ®Google Scholar
• Bouck, N. P., and G. DiMayorca. 1979. Evaluation of chemical carcinogenicity by in vitro neoplastic transformation. Methods Enzymol. 58:296-302.
   PubMedGoogle Scholar
• Bouck, N. P., and G. DiMayorca. 1982. Chemical carcinogens transform BHK cells by inducing a recessive mutation. Mol. Cell. Biol. 2:97-105.
   PubMed Web of Science ®Google Scholar
• Bouck, N. P., and M. Head. 1985. The majority of independently transformed BHK cell clones share a single functional lesion which determines anchorage independence and influences tumorigenicity. In Vitro Cell. Dev. Biol. 21:463-469.
   PubMed Web of Science ®Google Scholar
• Chan, D., A. Goate, and T. T. Puck. 1989. Involvement of vimentin in the reverse transformation reaction. Proc. Natl. Acad. Sci. USA 86:2747-2751.
   PubMedGoogle Scholar
• Chen, C., and H. O. Okayama. 1987. High-efficiency transformation of mammalian cells by plasmid DNA. Mol. Cell. Biol. 7:2745-2752.
   PubMed Web of Science ®Google Scholar
• DiMayorca, G., M. Greenblatt, T. Trauthen, A. Soller, and R. Giordano. 1973. Malignant transformation of BHK21 clone 13 cells in vitro by nitrosamines—a conditional state. Proc. Natl. Acad. Sci. USA 70:46-49.
   PubMedGoogle Scholar
• Eiden, M. V. Unpublished data.
   Google Scholar
• Ferrari, S., R. Battini, L. Kaczmarek, S. Kittling, B. Calabretta, J. Kimde Riel, V. Philiponis, J.-F. Wei, and R. Baserga. 1986. Coding sequence and growth regulation of the human vimentin gene. Mol. Cell. Biol. 6:3614-3620.
   PubMed Web of Science ®Google Scholar
• Ferrari, S., L. A. Cannizzato, R. Battini, K. Huebner, and R. Baserga. 1987. The gene encoding human vimentin is located on the short arm of chromosome 10. Am. J. Hum. Genet. 41:616-626.
   PubMed Web of Science ®Google Scholar
• Horowitz, J. M., D. W. Yandell, S.-H. Park, S. Canning, P. Whyte, K. Buchkovich, E. Harlow, R. A. Weinberg, and T. P. Dryja. 1989. Point mutational inactivation of the retinoblastoma antioncogene. Science 243:937-940.
   PubMed Web of Science ®Google Scholar
• Jarrett, O., and I. Macpherson. 1968. The basis for the tumorigenicity of BHK cells. Int. J. Cancer 3:654-662.
   PubMedGoogle Scholar
• Kumar, R., S. Saraswati, and M. Barbacid. 1990. Activation of ras oncogenes preceding the onset of neoplasia. Science 248:1101-1104.
   PubMed Web of Science ®Google Scholar
• Lazarides, E. 1982. Intermediate filaments: a chemically heterogeneous, developmentally regulated class of proteins. Annu. Rev. Biochem. 51:219-250.
   PubMed Web of Science ®Google Scholar
• Maniatis, T., E. F. Fritsch, and J. Sambrook. 1982. Molecular cloning: a laboratory manual. Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
   Google Scholar
• Mathew, C. G. P., K. S. Chin, D. F. Easton, K. Thorpe, C. Carter, G. I. Liou, S.-L. Fong, C. D. B. Bridges, H. Haak, A. C. Nieuwenhuijzen Kruseman, S. Schifter, H. H. Hansen, H. Telenius, M. Telenius-Berg, and B. A. J. Ponder. 1987. A linked genetic marker for multiple endocrine neoplasia type 2A on chromosome 10. Nature (London) 328:527-528.
   PubMed Web of Science ®Google Scholar
• Mathew, C. G. P., B. A. Smith, K. Thorpe, Z. Wong, N. J. Royle, A. J. Jeffrys, and B. A. J. Ponder. 1987. Deletion of genes on chromosome 1 in endocrine neoplasia. Nature (London) 328:524-527.
   PubMed Web of Science ®Google Scholar
• Okayama, H. O., M. Kawaichi, M. B. Brownstein, F. Lee, T. Yokota, and K. Arai. 1988. High effiency cloning of full-length cDNA: construction and screening of cDNA expression libraries for mammalian cells. Methods Enzymol. 45:3-28.
   Google Scholar
• Quax, W., W. V. Egberts, W. Hendriks, Y. Quax-Jeuken, and H. Bloemendal. 1983. The structure of the vimentin gene. Cell 35:215-223.
   PubMedGoogle Scholar
• Rastinejad, F., P. J. Polverini, and N. P. Bouck. 1989. Regulation of the activity of a new inhibitor of angiogenesis by a cancer suppressor gene. Cell 56:345-355.
   PubMed Web of Science ®Google Scholar
• Simpson, N. E., K. K. Kidd, P. J. Goodfellow, H. McDermid, S. Myers, J. R. Kidd, C. E. Jackson, A. M. V. Duncan, L. A. Farrer, K. Brasch, C. Castiglione, M. Genel, J. Gertner, C. R. Greenberg, J. F. Gusella, J. J. A. Holden, and B. N. White. 1987. Assignment of multiple endocrine neoplasia type 2A to chromosome 10 by linkage. Nature (London) 328:528-530.
   PubMed Web of Science ®Google Scholar
• Stoker, M., and I. MacPherson. 1964. Syrian hamster fibroblast cell line BHK 21 and its derivatives. Nature (London) 203:1355-1357.
   PubMedGoogle Scholar
• Stoler, A., and N. P. Bouck. 1985. Identification of a single chromosome in the normal human genome essential for suppression of hamster cell transformation. Proc. Natl. Acad. Sci. USA 82:570-574.
   PubMed Web of Science ®Google Scholar
• Varmus, H. E. 1984. The molecular genetics of cellular oncogenes. Annu. Rev. Genet. 18:553-612.
   PubMed Web of Science ®Google Scholar
• Weinberg, R. A. 1989. Positive and negative controls on cell growth. Biochemistry 28:8263-8269.
   PubMed Web of Science ®Google Scholar
• Westin, E. 1989. Oncogenes, p. 275-290. In A. Siriea (ed.), The pathology of neoplasia. Plenum Publishing Corp., New York.
   Google Scholar
• White, E., and R. Cipriani. 1989. Specific disruption of intermediate filaments and the nuclear lamina by the 19-kDa product of the adenovirus E1B oncogene. Proc. Natl. Acad. Sci. USA 86:9886-9890.
   PubMed Web of Science ®Google Scholar